Howe & Rusling Inc Eli Lilly & CO Transaction History

Howe & Rusling Inc

$1.16 Billion
Q3 2024

A detailed history of Howe & Rusling Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Howe & Rusling Inc holds 406 shares of LLY stock, worth $329,298. This represents 0.03% of its overall portfolio holdings.

Number of Shares

406

Previous 705 42.41%

Holding current value

$329,298

Previous $638,000 43.73%

% of portfolio

0.03%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $230,869 - $287,045	-299 Reduced 42.41%	406 $359,000
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $53,640 - $67,268	74 Added 11.73%	705 $638,000
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $37,288 - $43,958	-71 Reduced 10.11%	631 $367,000
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $1,304 - $1,797	3 Added 0.43%	702 $377,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $19,992 - $26,731	-57 Reduced 7.54%	699 $327,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $41,313 - $48,521	-133 Reduced 14.96%	756 $259,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6,752 - $7,868	21 Added 2.42%	889 $325,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $64,929 - $73,993	219 Added 33.74%	868 $281,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1,393 - $1,636	-5 Reduced 0.76%	649 $210,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 1.55%	654 $187,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1,551 - $1,908	-7 Reduced 1.08%	644 $149,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $541 - $700	-3 Reduced 0.46%	651 $149,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $7,887 - $10,210	-48 Reduced 6.84%	654 $122,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $28,309 - $37,460	217 Added 44.74%	702 $119,000
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 13.39%	485 $72,000
Q2 2020 Jul 15, 2020	SELL	$136.42 - $164.18 $544,179 - $654,914	-3,989 Reduced 87.69%	560 $92,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $2,500 - $3,094	-21 Reduced 0.46%	4,549 $631,000
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $2,105 - $2,457	-19 Reduced 0.41%	4,570 $506,000
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $444,126 - $522,769	3,990 Added 666.11%	4,589 $595,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $2,012 - $2,254	-19 Reduced 3.07%	599 $69,000
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $2,747 - $3,433	-32 Reduced 4.92%	618 $66,000
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $16,956 - $19,461	-224 Reduced 25.63%	650 $55,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $238,807 - $281,896	-3,218 Reduced 78.64%	874 $68,000
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $11,635 - $12,480	-142 Reduced 3.35%	4,092 $346,000
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $326,314 - $362,176	4,234	4,234 $362,000

Others Institutions Holding LLY

# of Institutions

4,073

Shares Held

737M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account